NOVOHEART LTD has a total of 14 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2017. It filed its patents most often in China, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are HUREL CORP, SCL BIOTECH LTD and PERFINITY BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Costa Kevin D | 8 |
#2 | Li Ronald A | 7 |
#3 | Li Ronald | 6 |
#4 | Tran David D | 3 |
#5 | Costa Kevin | 2 |
#6 | Li Dengwei | 1 |
#7 | Tran David | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019244044A1 | Ex vivo methods of screening for, and characterizing, cardiac therapeutics using preloaded cardiac tissues | |
EP3775886A2 | Modeling neurological disorders and ataxias with cardiac dysfunction using bioengineered heart tissues | |
CN111819442A | Bioreactor screening platform for modeling human system biology and screening for agents acting on muscle force of heart | |
WO2018029535A1 | Systems and methods for modeling disease and assessing adverse side effects of therapeutics therefor |